产品封面图

重组人p16-INK4a-TAT

收藏
  • ¥1838
  • peprotech
  • USA
  • 110-02T
  • 2025年12月08日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 英文名

      Cyclin-dependent kinase inhibitor 2A, Cyclin-dependent kinase 4 inhibitor A, CDK4I, p16INK4A, p16-INK4, Multiple tumor suppressor 1, MTS-1

    • 供应商

      研卉生物

    • 规格

      25ug

    重组人p16-INK4a-TAT(Recombinant Human p16-INK4a-TAT)
    别名:Cyclin-dependent kinase inhibitor 2A,
    Cyclin-dependent kinase 4 inhibitor A,
    CDK4I,
    p16INK4A,
    p16-INK4,
    Multiple tumor suppressor 1,
    MTS-1
    Description:
    p16-INK4a is a nuclear protein that regulates the cell cycle by inhibiting cyclin-dependent kinase-4 (CDK4) and CDK6. p16-INK4a inhibits CDK activity by binding to the CDK molecules in a manner that interferes with their ability to interact with cyclin D. This activity has the effect of suppressing tumor formation and growth, and of inducing replicative senescence in various normal cells, including stem cells. The expression of p16-INK4a steadily increases with age, and tends to accumulate in stem cell compartments. The deletion, rearrangement, or mutation of the p16-INK4a gene is frequently found in melanomas, as well as in certain other types of cancer. p16-INK4a and other transcription factors have been introduced into cells by DNA transfection, viral infection, or microinjection. Protein transduction using TAT fusion proteins represents an alternative methodology for introducing transcription factors and other nuclear proteins into primary, as well as transformed, cells. Recombinant Human p16-INK4a-TAT expressed in E. coli is an 18.0 kDa protein containing 167 amino-acid residues, including the 155 residues of full-length p16-INK4a and a 12-residue C-terminal TAT peptide (GYGRKKRRQRRR).
    AA Sequence:
    EPAAGSSMEP SADWLATAAA RGRVEEVRAL LEAGALPNAP NSYGRRPIQV MMMGSARVAE LLLLHGAEPN CADPATLTRP VHDAAREGFL DTLVVLHRAG ARLDVRDAWG RLPVDLAEEL GHRDVARYLR AAAGGTRGSN HARIDAAEGP SDIPDGYGRK KRRQRRR
    Source:
    E.coli
    Purity:
    Greater than 95% by SDS-PAGE gel and HPLC analyses.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • p16INK4A and Familial Melanoma

      . This phase is controlled by several protein complexes including those consisting of cyclin-dependent kinases (CDK4 and CDK6) and cyclin D. These complexes are inhibited by the INK4 family of proteins—p16INK4A , p15INK4B , p18INK4C , and p19INK4D . Genetic

    • Analysis of p16INK4a and Integrated HPV Genomes as Progression Markers

      that never develop a lesion. Only a small percentage of low-grade dysplasias finally grow out to invasive cancer. Several biomarkers can be used to identify lesions at risk for malignant progression. Overexpression of p16INK4a is induced by the viral oncoprotein E7

    • Sensitive Detection of Hypermethylated p16INK4a Alleles in Exfoliative Tissue Material

      Epigenetic DNA modification by aberrant methylation of cytosine residues is thought to be an important mechanism contributing to tumorigenesis. Methylation of cytosines normally occurs at distinct sites of the genome containing stretches

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥2580
    北京义翘神州科技股份有限公司(Sino Biological Inc.)
    2025年08月12日询价
    ¥2600
    上海研卉生物科技有限公司
    2025年10月18日询价
    询价
    武汉禾元生物科技股份有限公司
    2026年01月19日询价
    ¥2405
    北京百普赛斯生物科技股份有限公司
    2025年10月26日询价
    询价
    北京博生福生物技术有限责任公司
    2026年01月20日询价
    重组人p16-INK4a-TAT
    ¥1838